ZC3HC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.391800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.218000E-01
Normal-vs-Stage2
2.565600E-01
Normal-vs-Stage3
1.506570E-01
Normal-vs-Stage4
4.199200E-01
Stage1-vs-Stage2
1.907560E-01
Stage1-vs-Stage3
2.096000E-01
Stage1-vs-Stage4
5.193400E-01
Stage2-vs-Stage3
1.501050E-01
Stage2-vs-Stage4
8.637200E-01
Stage3-vs-Stage4
5.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.866600E-01
Normal-vs-AfricanAmerican
4.362400E-01
Normal-vs-Asian
4.034100E-02
Caucasian-vs-AfricanAmerican
9.433800E-01
Caucasian-vs-Asian
7.392100E-02
AfricanAmerican-vs-Asian
1.530200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.115600E-01
Normal-vs-Female
3.875000E-01
Male-vs-Female
5.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.184800E-01
Normal-vs-Age(41-60Yrs)
5.044600E-01
Normal-vs-Age(61-80Yrs)
2.345400E-01
Normal-vs-Age(81-100Yrs)
2.421200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.113000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.058000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.246200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.288610E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.744600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.632000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.859700E-02
Normal-vs-Daily Drinker
5.332800E-01
Normal-vs-Weekly Drinker
6.961400E-01
Normal-vs-Occasional Drinker
3.376800E-01
Normal-vs-Social Drinker
7.656200E-01
Non Drinker-vs-Daily Drinker
2.297800E-02
Non Drinker-vs-Weekly Drinker
2.081800E-02
Non Drinker-vs-Occasional Drinker
1.077420E-01
Non Drinker-vs-Social Drinker
1.198370E-03
Daily Drinker-vs-Weekly Drinker
7.501600E-01
Daily Drinker-vs-Occasional Drinker
5.783200E-01
Daily Drinker-vs-Social Drinker
4.115200E-01
Weekly Drinker-vs-Occasional Drinker
4.294600E-01
Weekly Drinker-vs-Social Drinker
6.955000E-01
Occasional Drinker-vs-Social Drinker
1.569380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.520000E-01
Normal-vs-Grade 2
8.753000E-01
Normal-vs-Grade 3
9.039200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.754820E-01
Grade 1-vs-Grade 3
4.240000E-01
Grade 1-vs-Grade 4
9.520000E-01
Grade 2-vs-Grade 3
3.328600E-01
Grade 2-vs-Grade 4
8.753000E-01
Grade 3-vs-Grade 4
9.039200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.645800E-01
Normal-vs-NonDiabetic
4.253400E-01
Diabetic-vs-NonDiabetic
3.447000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.433000E-01
Normal-vs-NoPancreatitis
3.478400E-01
Pancreatitis-vs-NoPancreatitis
8.012800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.353000E-01
Normal-vs-N1
2.900200E-01
N0-vs-N1
6.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.006400E-01
Normal-vs-TP53-NonMutant
6.360600E-01
TP53-Mutant-vs-TP53-NonMutant
4.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
